RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF

NCT04195282 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B
Acute-On-Chronic Liver Failure

Interventions

OTHER: Plasma exchange
OTHER: RL-1 Novel Human-derived Bio-artificial Liver Treatment

Sponsor

Third Affiliated Hospital, Sun Yat-Sen University